(2 years, 10 months ago)
Lords ChamberMy Lords, it is absolutely right to say that challenges to vaccine equity lie with supply and manufacturing constraints, pressures on health systems to administer available vaccines, supply chain issues such as export restrictions and tariff barriers, and vaccine confidence. These are the matters that we should be concentrating on.
My Lords, it is the turn of the Liberal Democrats. The noble Lord, Lord Jones of Cheltenham, wishes to speak virtually, and I think this is a convenient point to call him.
My noble friend makes a good point. It is interesting that, as reported in the Financial Times last week, Kate O’Brien, the WHO’s head of vaccines, said that the health body saw a
“very positive outlook for supply”
in 2022. But she cautioned that that was predicated on dose-sharing continuing, and manufacturers continuing to honour deals brokered under COVAX. This is the way forward.
My Lords, the noble Lord, Lord Campbell-Savours, wishes to speak virtually. I think this is a convenient time for me to call him.